Wednesday, August 3, 2022

Patient Registry Software Market: Emergence of cloud-based patient registry solutions

 The use of cloud-based patient registry solutions helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease. In addition, these solutions do not require any upfront capital investment for hardware and provide faster data transfer between organizations. Considering these advantages, the preference for cloud-based patient registry solutions is expected to increase among end users during the forecast period.

The global Patient registry software market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594  

Scope of the Report

The study categorizes the patient registry software market based on types of registry, types of software, pricing model, deployment model, types of database, functionality, end user and regional and global level.

Global Patient Registry Software Market, by Types of Registry

  • Patient Registry Software Market, By Type of Registry
    •  Introduction
    •  Disease Registry
      • Diabetes Registries
      • Cardiovascular Registries
      •   Cancer Registries
      •   Rare Disease Registries
      •   Asthma Registries
      •   Chronic Kidney Registries
      •   Orthopedic Registries
      •   Other Disease Registries
    •  Health Service Registeries
    •  Product Registeries
      •   Medical Device Registries
      •   Drug  Registries

Patient Registry Software Market, By Type of Software

  • Patient Registry Software Market, By Type of Software
    •  Introduction
    •  Integrated Software

Patient Registry Software Market, By Pricing Model

  • Patient Registry Software Market, By Pricing Model
    •  Introduction
    •  Subscription Model;
    •  Ownership Model

Patient Registry Software Market, By Deployment Model

  • Patient Registry Software Market, By Deployment Model
    •  Introduction
    •  On-Premise Model
    •  Cloud-Based Model

Patient Registry Software Market, By Type of Database

  • Patient Registry Software Market, By Type of Database
    •  Introduction
    •  Commercial Database
    •  Public Database

Patient Registry Software Market, By Functionality

  • Patient Registry Software Market, By Functionality
    •  Introduction
    •  Population Health Management
    •  Patient Care Management
    •  Medical Research & Clinical Studies
    •  Health Information Exchange
    •  Point-of-Care
    •  Product Outcome Evaluation

Patient Registry Software Market, By End User

  • Patient Registry Software Market, By End User
    •  Introduction
    •  Government Organizations and Third-Party Administrators.
    •  Hospitals & Medical Practices
    •  Private Payers
    •  Pharmaceutical, Biotechnology, and Medical Device Companies
    •  Research Centers

Global Patient Registry Software Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Uk
    • Germany
    • France
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Market Segmentation:

On the basis of type of registry, the disease registries segment accounted for the largest share of the patient registry software market in 2020. The large share of this segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe.

Based on end user, the hospitals & medical practices segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are growing prevalence of research, QM and improvement, facility planning and marketing, and monitoring patient outcomes.

Regional Analysis:

North America accounted for the largest share of the market in 2020, followed by Europe and Asia Pacific. The increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, increasing adoption of HCIT as a cost-containment measure are some of the factors driving the growth of the market in North America.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144694594 

Top Key Players:

Some of the prominent players in this patient registry software market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend, Inc. (US), Evado Clinical (Australia), WIRB Copernicus Group (US), Global Vision Technologies, Inc. (India), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), LUMEDX (US), Armus Corp (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data, Inc. (US).

 

Tuesday, August 2, 2022

Label-free Detection Market worth $626 million by 2025 - Exclusive Report by MarketsandMarkets™

 The Growth in label-free detection market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.

The global Label-free detection market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

Scope of the Report

 The study categorizes the label free detection market into the following segments and subsegments:

Label-free detection Market, by Product & Service

  • Instruments
  • Consumables
    • Biosensor Chips
    • Microplates
    • Reagents & Kits
  • Software & Services 

Label-free detection Market, by Technology

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Isothermal Titration Calorimetry
  • Differential Scanning Calorimetry
  • Other LFD Technologies

Label-free detection Market by Application

  • Binding Kinetics
  • Hit Confirmation
  • Lead Generation
  • Endogenous Receptor Detection
  • Binding Thermodynamics
  • Other Applications

Label-free detection Market, by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Other End Users

Label-free detection Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • The Middle East and Africa 

 

Market Segmentation:

On the basis of product & service, the market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems.

On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.

Regional Analysis:

In 2019, Asia Pacific region accounted for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research.

Get 10% Customization on this Research Report: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593

Top Key Players: -

Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US)

Monday, August 1, 2022

Albumin & Creatinine Tests Market: Integrated and automated systems for overall urine analysis

 

The integration of automated urine sediment and urine biochemical analysis in one system allows rapid and easy urine analysis. At present, standalone automated urine sediment analyzers help standardize sediment & biochemical analysis with minimum operator interference and enable the rapid analysis of urine samples. Such integrated systems have a huge potential in the automated devices market and can help large hospitals and diagnostic labs to manage their workloads efficiently. As a result, this area has been identified as an opportunity in the market.

The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568

Scope of the Report

This report categorizes the albumin & creatinine tests market into the following segments and subsegments:

By Product

  • Dipsticks & Kits
  • Analyzers
  • Cartridges
    • Cartridges for POC Analyzers
    • Cartridges for Table-Top Analyzers
  • Reagents & Other Consumables

By Type

  • Urine Tests
    • Urine Albumin Tests
    • Urine Creatinine Tests
    • Glycated Albumin
  • Blood & Serum Creatinine Tests

By End User

  • Hospitals & Clinics’
  • Diagnostic Laboratories
  • Research Laboratories & Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • South Korea
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Market Segmentation:

Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.

Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.

Regional Analysis: -

The global ACR Test Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share in the global market. The large share of this regional segment can primarily be attributed to the growth in demand for rapid urine tests, increasing prevalence of chronic conditions leading to various kidney diseases, rising government initiatives, and growing geriatric population.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=156696568

Top Key Players: -

The major players operating in this ACR Tests Market are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc. (Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co., Ltd. (China).

 

Antibody Therapeutics Market : Driven by Advances in Biologics and Expanding Clinical Applications

The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5...